Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases
Investigative Opthalmology & Visual Science · 30.05.2023 · 64 (5) · 28
DOI: 10.1167/iovs.64.5.28 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 30.05.2023. Verfasst von Dhyana Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapeutics and Advanced Therapies, Research and Development, Medicines and Healthcare products Regulatory Agency, London, United Kingdom. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Macular Edema, Wet Macular Degeneration. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Biotherapeutics and Advanced Therapies, Research and Development, Medicines and Healthcare products Regulatory Agency, London, United Kingdom.
- Centre for Cardiometabolic and Vascular Science, Division of Medicine, University College London, London, United Kingdom.
Zitieren
APA
Sharma, D., Zachary, I., & Jia, H. (2023). Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases. Investigative Opthalmology & Visual Science, 64(5), 28. https://doi.org/10.1167/iovs.64.5.28
Vancouver
Sharma D, Zachary I, Jia H. Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases. Investigative Opthalmology & Visual Science. 2023;64(5):28. doi:10.1167/iovs.64.5.28
BibTeX
@article{Sharma2023,
author = {Sharma, Dhyana and Zachary, Ian and Jia, Haiyan},
title = {Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
volume = {64},
number = {5},
pages = {28},
doi = {10.1167/iovs.64.5.28}
}
EUVIMED